N	B:C0754710
-	I:C0754710
Terminal	I:C0754710
Pro-B	I:C0754710
-	I:C0754710
Type	I:C0754710
Natriuretic	I:C0754710
Peptide	I:C0754710
as	O
a	O
Biomarker	B:C0005516
for	O
Loss	B:C0026846
of	I:C0026846
Muscle	I:C0026846
Mass	I:C0026846
in	O
Prevalent	O
Hemodialysis	B:C0019004
Patients	O
.	O

Protein	B:C0012634
-	I:C0012634
energy	I:C0012634
wasting	I:C0012634
(	O
Protein	B:C0012634
-	I:C0012634
energy	I:C0012634
wasting	I:C0012634
)	O
is	O
common	O
in	O
hemodialysis	B:C0019004
(	O
hemodialysis	B:C0019004
)	O
patients	O
.	O

A	O
recent	O
study	B:C2603343
demonstrated	O
that	O
a	O
high	O
level	O
of	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
(	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
)	O
may	O
be	O
associated	O
with	O
Protein	B:C0012634
-	I:C0012634
energy	I:C0012634
wasting	I:C0012634
in	O
those	O
patients	O
.	O

This	O
prospective	B:C1709709
study	I:C1709709
aimed	O
to	O
assess	O
the	O
association	O
of	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
with	O
body	O
composition	O
and	O
muscle	B:C0026846
loss	I:C0026846
.	O

A	O
cohort	B:C0599755
of	O
prevalent	O
hemodialysis	B:C0019004
patients	O
(	O
n	O
=	O
238	O
)	O
was	O
examined	O
.	O

Blood	B:C0178913
samples	I:C0178913
were	O
obtained	O
at	O
baseline	O
to	O
measure	O
high	B:C0006560
-	I:C0006560
sensitive	I:C0006560
C-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
(	O
high	B:C0006560
-	I:C0006560
sensitive	I:C0006560
C-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
)	O
,	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
(	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
)	O
,	O
adiponectin	B:C0389071
and	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
.	O

Nutritional	B:C0392209
status	I:C0392209
and	O
changes	O
in	O
muscle	B:C0240417
mass	I:C0240417
were	O
assessed	O
by	O
subjective	B:C0451514
global	I:C0451514
assessment	I:C0451514
,	O
percentage	O
creatinine	O
generation	O
rate	O
(	O
%CGR	O
)	O
,	O
creatinine	O
index	O
(	O
CI	O
)	O
and	O
lean	B:C0424678
body	I:C0424678
mass	I:C0424678
(	O
lean	B:C0424678
body	I:C0424678
mass	I:C0424678
)	O
estimated	O
by	O
dual	B:C1510486
-	I:C1510486
energy	I:C1510486
X	I:C1510486
-	I:C1510486
ray	I:C1510486
absorptiometry	I:C1510486
(	O
dual	B:C1510486
-	I:C1510486
energy	I:C1510486
X-	I:C1510486
ray	I:C1510486
absorptiometry	I:C1510486
)	O
.	O

The	O
%CGR	O
and	O
CI	O
were	O
calculated	O
five	O
times	O
for	O
one	O
year	O
,	O
and	O
dual	B:C1510486
-	I:C1510486
energy	I:C1510486
X	I:C1510486
-	I:C1510486
ray	I:C1510486
absorptiometry	I:C1510486
was	O
performed	O
at	O
baseline	O
and	O
one	O
year	O
later	O
.	O

Cardiac	B:C0232164
function	I:C0232164
was	O
estimated	O
by	O
ultrasonography	B:C0041618
at	O
baseline	O
.	O

N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
was	O
significantly	O
higher	O
in	O
hemodialysis	B:C0019004
patients	O
with	O
Protein	B:C0012634
-	I:C0012634
energy	I:C0012634
wasting	I:C0012634
.	O

High	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
was	O
associated	O
with	O
cardiac	B:C3277906
dysfunction	I:C3277906
,	O
increased	B:C1963867
levels	I:C1963867
of	I:C1963867
hsCRP	I:C1963867
and	O
interleukin	B:C0877589
-	I:C0877589
6	I:C0877589
,	O
and	O
serially	O
decreased	O
levels	O
of	O
the	O
indexes	B:C0600653
for	O
muscle	B:C0240417
mass	I:C0240417
.	O

Multiple	O
regression	O
analysis	O
adjusted	O
with	O
confounders	O
showed	O
that	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
was	O
an	O
independent	O
predictor	O
for	O
decrease	O
in	O
lean	B:C0424678
body	I:C0424678
mass	I:C0424678
and	O
serial	O
lower	O
levels	O
of	O
%CGR	O
and	O
CI	O
.	O

In	O
conclusion	O
,	O
the	O
present	O
study	B:C2603343
demonstrated	O
a	O
novel	O
association	O
between	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
and	O
muscle	B:C0026846
loss	I:C0026846
.	O

N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
may	O
be	O
an	O
independent	O
biomarker	B:C0005516
for	O
malnutrition	B:C0162429
in	O
hemodialysis	B:C0019004
patients	O
,	O
especially	O
in	O
patients	O
with	O
muscles	B:C0026846
loss	I:C0026846
,	O
regardless	O
of	O
chronic	B:C0021376
inflammation	I:C0021376
,	O
cardiac	B:C3277906
dysfunction	I:C3277906
,	O
or	O
overhydration	B:C0392689
.	O

